两种营养评分与转移性结直肠癌治疗毒性和生存的相关性:AGEO前瞻性多中心研究
该前瞻性多中心观察性研究纳入168例未经治疗的转移性结直肠癌患者,在一线化疗开始时行PG-SGA和NRI营养评估。多因素分析显示PG-SGA定义的营养不良与化疗相关≥2级临床毒性(OR 3.7,95%CI 1.7-8.4,p=0.001)和OS(HR 2.6,95%CI 1.3-5.3,p=0.006)显著相关,但与PFS无关;NRI则与这些参数均无显著关联。
要点
- PG-SGA评估的营养不良与mCRC患者化疗相关≥2级临床毒性风险升高独立相关。
- PG-SGA评估的营养不良与mCRC患者总生存期缩短独立相关,但与PFS无关。
- NRI评估的营养不良与治疗毒性和生存均无显著关联。
核心结论
- PG-SGA评分虽在每日肿瘤实践中操作更复杂,但因与OS和治疗相关毒性等临床相关肿瘤学结局强关联,似乎是mCRC患者最佳营养评估工具。
研究设计与样本
- 前瞻性多中心观察性研究,纳入168例来自法国8个中心的未经治疗的转移性结直肠癌患者。
- 在一线化疗开始时进行PG-SGA和NRI营养评估,并按NCI CTCAE 4.0版记录治疗相关毒性。
- PFS和OS从治疗开始计算。
主要发现
- 根据PG-SGA,41%的患者被判定为营养不良;根据NRI,56%的患者被判定为营养不良。
- 多因素分析中,PG-SGA定义的营养不良与化疗相关≥2级临床毒性显著相关(OR 3.7;95%CI 1.7-8.4;p=0.001)。
- PG-SGA定义的营养不良与OS显著相关(HR 2.6;95%CI 1.3-5.3;p=0.006),但与PFS无显著关联(HR 1.5;95%CI 0.8-2.6;p=0.2)。
- NRI定义的营养不良与上述耐受性和疗效参数均无显著关联。
临床怎么用
- 在mCRC患者一线化疗前可采用PG-SGA进行营养评估,以识别治疗毒性风险高和生存预后差的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The Patient-Generated Subjective Global Assessment (PG-SGA) is currently the standard nutritional assessment tool for patients with cancer. In a retrospective assessment of a prospective cohort, we showed that the Nutritional Risk Index (NRI) seemed to be associated with treatment toxicity and survival in patients with metastatic colorectal cancer (mCRC). OBJECTIVE: The objective of this study was to compare these two nutritional tools (PG-SGA and NRI) on their correlation with chemotherapy-related toxicity and survival in non-pre-treated patients with mCRC. METHODS: This prospective multicentre observational study enrolled non-pre-treated patients with mCRC. PG-SGA and NRI were performed at the onset of first-line chemotherapy. Treatment-related toxicities were registered according to National Cancer Institute Common Toxicity Criteria Adverse Event version 4.0. Progression-free survival (PFS) and overall survival (OS) were calculated from the start of treatment. RESULTS: A total of 168 patients were included from eight French centres. Patients were considered malnourished in 41% of cases according to PG-SGA and 56% of cases according to the NRI. In multivariate analysis, malnutrition according to PG-SGA was significantly associated with chemotherapy-related grade ≥2 clinical toxicities (odds ratio: 3.7; 95% confidence interval [CI]: 1.7-8.4; p = 0.001) and OS (hazard ratio [HR]: 2.6; 95% CI: 1.3-5.3; p = 0.006), but not with PFS (HR: 1.5; 95% CI: 0.8-2.6; p = 0.2). Conversely, malnutrition according to the NRI was not significantly associated with these tolerance and efficacy parameters. CONCLUSION: Although more complex to perform in daily oncology practice, the PG-SGA score appears to be the best nutritional assessment tool because of its strong association with clinically relevant oncological outcomes such as OS and treatment-related toxicities in patients with mCRC.
引用
- Gallois C, Artru P, Lièvre A, et al. Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre study. Eur J Cancer. 2019. PMID: 31415985. doi:10.1016/j.ejca.2019.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。